4-Piperidinecarboxamide, 1-[3-[8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-2,6-dioxo-1H-purin-1-yl]propyl]-N-phenyl- manufacturers
|
| | 4-Piperidinecarboxamide, 1-[3-[8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-2,6-dioxo-1H-purin-1-yl]propyl]-N-phenyl- Basic information |
| Product Name: | 4-Piperidinecarboxamide, 1-[3-[8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-2,6-dioxo-1H-purin-1-yl]propyl]-N-phenyl- | | Synonyms: | 4-Piperidinecarboxamide, 1-[3-[8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-2,6-dioxo-1H-purin-1-yl]propyl]-N-phenyl-;DPP-4/GPR119 modulator 2 | | CAS: | 2010927-65-6 | | MF: | C30H40N8O3 | | MW: | 560.69 | | EINECS: | | | Product Categories: | | | Mol File: | 2010927-65-6.mol | ![4-Piperidinecarboxamide, 1-[3-[8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-2,6-dioxo-1H-purin-1-yl]propyl]-N-phenyl- Structure](CAS/20210305/GIF/2010927-65-6.gif) |
| | 4-Piperidinecarboxamide, 1-[3-[8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-2,6-dioxo-1H-purin-1-yl]propyl]-N-phenyl- Chemical Properties |
| density | 1.32±0.1 g/cm3(Predicted) | | pka | 14.58±0.70(Predicted) |
| | 4-Piperidinecarboxamide, 1-[3-[8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-2,6-dioxo-1H-purin-1-yl]propyl]-N-phenyl- Usage And Synthesis |
| Uses | DPP-4/GPR119 modulator 2 (Compound 20i) is a dipeptidyl peptidase IV (DPP-IV) inhibitor and GPR119 agonist with an IC50 of 0.22 μM for DPP-IV and an EC50 of 0.95 μM for GPR119. DPP-4/GPR119 modulator 2 can be used for diabetes research[1]. DPP-4/GPR119 modulator 2 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups. | | IC 50 | DPP-4 | | References | [1] Li G, et al. The optimization of xanthine derivatives leading to HBK001 hydrochloride as a potent dual ligand targeting DPP-IV and GPR119. Eur J Med Chem. 2020 Feb 15;188:112017. DOI:10.1016/j.ejmech.2019.112017 |
| | 4-Piperidinecarboxamide, 1-[3-[8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-2,6-dioxo-1H-purin-1-yl]propyl]-N-phenyl- Preparation Products And Raw materials |
|